The US Food and Drug Administration officially shuttered its Alternative Summary Reporting (ASR) Program today and released to the public millions of adverse event reports received by the agency between 1999 and 2019.
The move comes more than a month after the FDA announced it would end its problematic program, which caused reports of medical device failures to be hidden from the public
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?